SAM
IRMD icon

Smartleaf Asset Management’s iRadimed IRMD Stock Holding History

Smartleaf Asset Management’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$855 Sell
9
-5
-36% -$500 ﹤0.01% 3144
2025
Q4 		$1.37K Sell
14
-131
-90% -$11.2K ﹤0.01% 3096
2025
Q3 		$10.2K Buy
+145
New +$9.66K ﹤0.01% 2101

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Smartleaf Asset Management's IRMD Position: Q1 2026 in Review

Smartleaf Asset Management reduced its iRadimed (IRMD) stake by 36% in Q1 2026, selling an estimated $500 and leaving 9 shares worth $855. The position accounts for ﹤0.01% of the portfolio, ranked #3144.

Smartleaf Asset Management first reported a position in IRMD in Q3 2025 and has held it in 3 quarters since. The position peaked at $10.2K in Q3 2025. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • Smartleaf Asset Management held 9 shares of iRadimed worth $855 as of Q1 2026.
  • Smartleaf Asset Management sold 5 iRadimed shares in Q1 2026, an estimated $500.
  • iRadimed made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q1 2026, its #3144 holding.
  • Smartleaf Asset Management first reported a position in iRadimed in Q3 2025 and has held it in 3 quarters since.
  • Smartleaf Asset Management's iRadimed position peaked at $10.2K in Q3 2025.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.